| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $844,183 ) |
| | 2027 | 2027 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R25ES034923 | Environmental Health Sciences Research for Indigenous Scholar Engagement (EHS-RISE) | 000 | 4 | NIH | 11/18/2026 | $129,510 |
| | 2027 | 2027 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01ES034690 | In Vitro to In Vivo Extrapolation of Toxicant Effects on Ovarian Function | 001 | 3 | NIH | 11/3/2026 | $705,174 |
| | 2027 | 2027 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS105680 | Establishing the Function of TMEM184B in mTORC1 Regulation and Synaptic Maintenance | 000 | 9 | NIH | 11/16/2026 | $398,827 |
| | 2027 | 2027 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31AG101924 | Cerebral microvascular dysfunction in humanized ApoE4 knock-in mice | 000 | 1 | NIH | 11/18/2026 | $43,487 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL178630 | ATF6 as a Regulator of Atrial Myocyte ER Proteostasis | 000 | 1 | NIH | 10/28/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R01OH013032 | Nurse Work Stress, Cardiovascular Health, & Adverse Pregnancy Outcomes | 01 | 1 | CDC | 11/3/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U1U42527 | Regional Telehealth Resource Centers | 01 | 5 | HRSA | 10/14/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U7703034 | MODEL STATE-SUPPORTED AHEC PROGRAM | 01 | 32 | HRSA | 11/6/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U7703034 | MODEL STATE-SUPPORTED AHEC PROGRAM | 01 | 32 | HRSA | 11/6/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31DK145020 | The Impact of Acid Ceramidase in Myeloid Cells on Intestinal Inflammation | 000 | 1 | NIH | 11/17/2026 | -$24,317 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | UB631687 | Public Health Training Centers | 01 | 9 | HRSA | 10/22/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DK102619 | Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease | 000 | 9 | NIH | 10/12/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U48DP006838 | SIP24-008 Economic analysis of an evidence-based MEW epilepsy self-management intervention (MINDSET) in community and healthcare settings. | 01 | 3 | CDC | 10/30/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U48DP006838 | SIP24-008 Economic analysis of an evidence-based MEW epilepsy self-management intervention (MINDSET) in community and healthcare settings. | 01 | 3 | CDC | 10/30/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA259570 | Phase separation control of transcription in Ewing sarcoma | 000 | 5 | NIH | 11/3/2026 | $0 |
| | 2027 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | T9632508 | Advanced Nurse Education-Sexual Nurse Assault Examiner program | 01 | 9 | HRSA | 11/19/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DE030682 | Multimodal Intraoral Imaging System for Oral Cancer Detection and Diagnosis in Low Resource Setting | 000 | 5 | NIH | 11/6/2026 | -$202,254 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R00HL155492 | Cardiac ryanodine receptor and oxidative stress | 000 | 5 | NIH | 11/8/2026 | -$5,957 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01AG082541 | The role of CMV in HIV-associated accentuated aging | 000 | 3 | NIH | 11/10/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL151772 | Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities | 000 | 5 | NIH | 10/28/2026 | -$4 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL151772 | Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities | 000 | 5 | NIH | 10/28/2026 | -$27 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21AI184072 | Ionic liquid-based nanoemulsion containing combination antiretroviral drugs forthe transdermal treatment of pediatric HIV infection | 000 | 2 | NIH | 10/21/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | P01AI148104 | Binational Early Asthma & Microbiome Study (BEAMS) | 000 | 6 | NIH | 10/14/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U48DP006838 | SIP24-008 Economic analysis of an evidence-based MEW epilepsy self-management intervention (MINDSET) in community and healthcare settings. | 01 | 3 | CDC | 10/30/2026 | $0 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HD106413 | Multi-site, longitudinal trial evaluating the efficacy, mechanisms, and moderators of service dogs for military Veterans with PTSD | 000 | 5 | NIH | 11/9/2026 | -$223 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA262719 | Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis | 000 | 5 | NIH | 10/26/2026 | -$22,982 |
| | 2027 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01ES034690 | In Vitro to In Vivo Extrapolation of Toxicant Effects on Ovarian Function | 000 | 2 | NIH | 10/26/2026 | $0 |
| | 2027 | 2024 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS114913 | Precision and binding as two dimensions of medial temporal lobe amnesia | 000 | 5 | NIH | 10/20/2026 | -$50,756 |
| | 2027 | 2024 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U48DP006838 | SIP24-008 Economic analysis of an evidence-based MEW epilepsy self-management intervention (MINDSET) in community and healthcare settings. | 01 | 3 | CDC | 10/30/2026 | $0 |
| | 2027 | 2024 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21DC020257 | Language as a Candidate Marker of FXTAS in FMR1 Premutation Carriers | 000 | 4 | NIH | 10/23/2026 | -$125,679 |
| | 2027 | 2024 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21AI177824 | Disrupting the mosquito larval midgut using novel pH responsive compounds | 000 | 2 | NIH | 11/3/2026 | -$618 |
| | 2027 | 2023 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL132523 | Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life | 000 | 8 | NIH | 10/2/2026 | $1 |
|
 | Issue Date FY: 2026 ( Subtotal = $208,882,800 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | U01AG095263 | Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat AD | 000 | 1 | NIH | 9/10/2026 | $2,659,106 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R56AI177505 | Ionic Liquids to improve oral bioavailability and in vivo efficacy of oxfendazole | 000 | 1 | NIH | 9/17/2026 | $779,407 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R01GM164325 | Investigating the role of mechanical signaling in adverse implant-tissue interaction | 000 | 1 | NIH | 9/11/2026 | $334,505 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R01ES039490 | PFAS Exposure, PFAS Mitigation, and ADRD Biomarkers and Cognition | 000 | 1 | NIH | 9/3/2026 | $762,573 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | T7320662 | Leadership Education in Neurodevelopmental and Related Disorders Training Program | 03 | 16 | HRSA | 8/12/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R01AG091320 | Rescue of synaptic loss and pathology in Alzheimer's mouse model by enhancing MET receptor tyrosine kinase signaling | 000 | 1 | NIH | 9/3/2026 | $616,013 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | T7320662 | Leadership Education in Neurodevelopmental and Related Disorders Training Program | 02 | 16 | HRSA | 6/16/2026 | $161,250 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | T7320662 | Leadership Education in Neurodevelopmental and Related Disorders Training Program | 00 | 17 | HRSA | 9/23/2026 | $477,057 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R21AR087779 | MYBPC1-targeted therapeutic discovery platform for treatment of distal arthrogryposis | 000 | 1 | NIH | 9/2/2026 | $375,381 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | F32AG104234 | Thought as a health marker: linking dynamics of self-generated thoughts and neural health in aging | 000 | 1 | NIH | 9/2/2026 | $76,780 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | RF1NS149974 | Pathological relevance of TDP-43 interactions with translation machinery in neurodegeneration | 000 | 1 | NIH | 8/31/2026 | $1,764,771 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R35CA294022 | Understanding and Exploiting Loss of Y in Cancer | 000 | 2 | NIH | 9/8/2026 | $923,709 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R01HL183250 | Duerme Mejor: Promoting Sleep Health at the US-Mexico Border | 000 | 1 | NIH | 8/28/2026 | $739,230 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31ES038410 | Impact of Heat Stress on Drug Metabolizing Enzyme Expression and Function | 001 | 1 | NIH | 5/8/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31ES038410 | Impact of Heat Stress on Drug Metabolizing Enzyme Expression and Function | 000 | 1 | NIH | 5/8/2026 | $43,222 |
| | 2026 | 2026 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R21TW013364 | Mobile Platform for Oral Cancer Screening and Diagnosis in Low and MiddleIncome Countries (LMICs) | 000 | 1 | NIH | 9/8/2026 | $130,784 |
|